Omnic Ocas 0.4 mg tablets

Omnic Ocas is a well-known pharmaceutical brand containing Tamsulosin hydrochloride, primarily used for treating symptoms of an enlarged prostate. The brand is owned and marketed by Astellas Pharma, a global pharmaceutical leader formed through the 2005 merger of Yamanouchi Pharmaceutical and Fujisawa Pharmaceutical.

While the brand has its roots in Japan, its manufacturing footprint is global. For the European market, production is often localized through high-tech facilities in the Netherlands (Meppel) and Spain (Madrid/León), ensuring compliance with regional health regulations. Astellas Pharma operates as a multinational entity, driving innovation in urology, oncology, and nephrology from its headquarters in Tokyo.